Samsung C&T, Samsung Biologics Invest 1.2 Trillion Won
[Asia Economy Reporter Choi Dae-yeol] Samsung C&T announced on the 18th that it will invest 1.2168 trillion KRW in its affiliate Samsung Biologics as part of expanding its bio business investments. It will participate in the rights offering subscription.
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Samsung Labor-Management Strikes Dramatic Deal, But Issues Remain... 'Division Fairness and Operating Profit Link' Domino Effect
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
